Evonik outlines polyester exit and job cuts, shares in MDAX chemicals spotlight
25.06.2026 - 15:02:40 | ad-hoc-news.de
By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-25, 15:02.
Evonik (DE000EVNK013) is pushing ahead with a far-reaching restructuring that will see it exit polyester activities and shrink its workforce materially. The MDAX-listed specialty chemicals group plans 3,200 job cuts by 2029 and a full withdrawal from polyester by 2027, according to recent sector reporting.
What Reuters and peers report
Industry analysis highlights that Evonik intends to cut around 3,200 roles worldwide by 2029, roughly 2,150 of them in Germany, as part of a multi-year efficiency program in its chemicals portfolio. Sector commentary on Evonik’s restructuring The group also aims to exit its global polyester business, which generates roughly €150 million in annual sales but has been structurally unprofitable.
The polyester shutdown is planned in stages through 2027 and affects sites in Witten and Marl in Germany, as well as operations in Shanghai. Details on locations and timeline Evonik positions the move as a shift away from low-return commodity-like activities toward higher-margin specialty products, in line with similar portfolio moves at European peers such as BASF and Clariant.
Operations and sector backdrop
The planned cuts come against a backdrop of prolonged weakness in parts of the European chemical sector, where high energy costs and subdued industrial demand have pressured margins. Analysts see Evonik’s measures as part of a broader trend of capacity rationalization and focus on more profitable specialty segments. Reuters overview of European chemicals The company continues to emphasize growth areas such as additives, nutrition ingredients and high-performance materials.
On the equity side, consensus data compiled by market platforms show that several analysts rate Evonik with a neutral to positive stance, reflecting the balance between restructuring costs and potential long-term margin benefits. Analyst consensus on Evonik As a specialty chemicals name in the MDAX, Evonik remains closely watched by investors looking for cyclical recovery in European industry.
All news and analysis on the Evonik shares
Further company releases, analyst assessments and price data on Evonik can be found in the dedicated topic section.
How Evonik makes its money
Evonik generates most of its revenue from specialty chemicals in segments such as Nutrition & Care, Resource Efficiency and Performance Materials, supplying additives, intermediates and functional materials to sectors including automotive, construction, consumer goods and life sciences. A representative product line is its high-performance additives for plastics processing.
Where the Evonik shares trade today
The Evonik shares (DE000EVNK013) trade on Xetra, where they were last quoted at 18.50 euros as of 2026-06-25, 14:55.
Key data on the Evonik shares
- Company: Evonik Industries AG
- ISIN: DE000EVNK013
- WKN: EVNK01
- Ticker: EVK
- Trading venue: Xetra
- Price (as of 2026-06-25, 14:55): 18.50 EUR
- Market cap: 8.6 billion EUR (as of 2026-06-25)
- Sector / industry: Specialty Chemicals
- Index membership: MDAX
- Next earnings date: 2026-08-09
Disclaimer: This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer or solicitation to buy or sell any securities. All information is based on sources believed to be reliable, but no guarantee is given for completeness or accuracy.
